Oncolytics Biotech
ONCY
#10266
Rank
A$79.53 M
Marketcap
A$0.61
Share price
-0.54%
Change (1 day)
-63.59%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2026 (TTM): -A$56.44 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$41.74 Million a decrease over its 2024 earnings that were of -A$34.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$56.44 Million35.22%
2025 -A$41.74 Million20.47%
2024 -A$34.65 Million-5.22%
2023 -A$36.55 Million24.73%
2022 -A$29.31 Million-1.09%
2021 -A$29.63 Million5.72%
2020 -A$28.03 Million25.24%
2019 -A$22.38 Million28.77%
2018 -A$17.38 Million1.15%
2017 -A$17.18 Million5.2%
2016 -A$16.33 Million9.85%
2015 -A$14.87 Million-36.67%
2014 -A$23.48 Million-26.64%
2013 -A$32 Million-38.4%
2012 -A$51.94 Million27%
2011 -A$40.9 Million44.32%
2010 -A$28.34 Million35.97%
2009 -A$20.85 Million-3.27%
2008 -A$21.55 Million-10.71%
2007 -A$24.13 Million28.33%
2006 -A$18.81 Million40.52%
2005 -A$13.39 Million-13.75%
2004 -A$15.52 Million115.72%
2003 -A$7.2 Million16.58%
2002 -A$6.17 Million-4.4%
2001 -A$6.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$47.90 B-87,917.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.98 B-31,232.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.1 Billion 1,899.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.83 Million-85.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.28 B-4,295.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$41.41 Million-24.09%๐Ÿ‡บ๐Ÿ‡ธ USA